Texas HIV Testing Consent and Applicant Notice

Texas law sets a specific consent and notice process for HIV-related tests requested in connection with insurance. The applicant should know how the result will be used, authorize the test in writing on the required form, and receive notice of a positive result through the channel specified by law.

Explain the test and obtain separate authorization

Texas Insurance Code § 545.053 requires the issuer, before the test, to explain to the person tested or an authorized representative how the test will be used and to obtain written authorization. The authorization must be on a form adopted by the commissioner and separate from any other document presented to the applicant or authorized representative. A general signature on an insurance application is not a substitute for this separate authorization.

What the issuer may ask

Section 545.054 permits an issuer to ask whether an applicant tested positive on an HIV-related test or has been diagnosed with HIV or AIDS. It prohibits asking whether the applicant has been tested for exposure to HIV or received a negative result from a specific test for HIV exposure or a related sickness or medical condition. This distinction protects the applicant’s testing history and negative results while allowing the limited questions specified by statute.

Written notice of a positive result

Under § 545.055, an applicant must receive written notice of a positive HIV-related test result from a physician the applicant designated. If no physician was designated, notice is given through the Texas Department of State Health Services under the statutory procedure. The result is not simply delivered through an underwriter’s adverse decision. Separate rules govern whether and when a positive result may support an adverse underwriting decision, including required testing protocols.

Keep the steps distinct

• Before testing: explain the test’s use.
• Before testing: obtain the commissioner-adopted written authorization on a separate form.
• After a positive result: provide written notice through the designated physician or, if none, the state health department.
• For underwriting: apply the separate protocol and limitations in the Code; do not assume consent alone authorizes any decision.
• Protect test information in accordance with applicable confidentiality and privacy rules.

The insurer must explain the test before authorization

Texas Insurance Code Chapter 545 regulates covered HIV-related testing sought in the insurance application process. The applicant must receive an explanation of how the test will be used and provide written authorization on the commissioner-adopted form. The authorization is separate from other application documents; it is not satisfied by a broad generic medical release alone. A producer should use the current approved form, explain it without pressuring the applicant, and allow the applicant to ask how the information will affect underwriting.

Consent does not mean a positive result is disclosed casually

The statute sets a specific notification process for a positive result. Written notice is provided by a physician designated by the applicant or, if none is designated, through the state health department under the law’s framework. The result is sensitive medical information and should be handled through authorized confidential channels. The agent should not call the applicant with an interpretation, leave a result in a general voicemail, or send it to an employer or lender. Follow the designated physician and carrier process.

Underwriting use and privacy

A test may be relevant to evaluating an application, but use of the result is constrained by law, consent, and underwriting rules. Keep the consent and test request separate from general application materials as required. Limit access to personnel with a need to know, and transmit data securely. If the applicant declines authorization, explain that the insurer may be unable to complete evaluation; do not imply that the applicant has already consented by applying for insurance.

A correct process sequence

First identify that the insurer is requesting a covered HIV-related test. Explain its use and obtain the current Texas authorization form before testing. Route the test through the approved provider and ensure results go to designated recipients. If positive, apply the statutory written-notice route. Keep records of authorization and notice without unnecessarily duplicating results. For a question about testing performed for a different purpose, determine whether Chapter 545 applies rather than assuming every HIV test uses the insurance-application rule.

Common exam errors

Do not treat verbal consent as sufficient, combine the required authorization with unrelated application language, or have the insurance agent deliver a positive result contrary to the designated process. Do not assume a positive result automatically means a policy denial; the insurer applies underwriting rules to an authorized test result. Chapter 545 governs consent and notice, while privacy laws and company procedures govern handling. Use the TDI-adopted form and current statute, not an outdated generic release.

Applicant choice and consequences

An applicant can decide whether to authorize a test, but the insurer may not be able to complete underwriting without requested evidence. Explain that choice plainly and avoid implying that refusal is itself a positive result. The carrier may decline, postpone, or make another underwriting decision under its rules. The applicant should receive information about the purpose and handling of the test before signing. Keep a dated copy of the separate form so the consent can be shown later.

If the result is disputed or mishandled

The applicant can ask the designated physician about the result and follow ordinary medical-record correction procedures if information is inaccurate. If the result was sent to an unauthorized recipient, document what was disclosed, to whom, and when, then contact the insurer’s privacy office and the appropriate regulator. The producer should not circulate a copy to resolve a dispute unless authorized. Chapter 545’s consent and notice process is specific; general medical-release forms do not replace it.

Exam takeaway

Remember separate written authorization on the commissioner’s form and written positive-result notice through the applicant’s chosen physician, or the state health department if no physician is named. Testing consent and underwriting action are separate legal steps.